Provided by Tiger Trade Technology Pte. Ltd.

MRBL Enhanced Equity ETF

51.27
-0.3457-0.67%
Post-market: 51.270.00000.00%16:10 EDT
Volume:214
Turnover:10.99K
Market Cap:12.31M
PE:- -
High:51.27
Open:51.62
Low:51.27
Close:51.62
52wk High:52.39
52wk Low:42.17
Shares:240.00K
Float Shares:240.00K
Volume Ratio:1.03
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Company Profile

Company Name:
MRBL Enhanced Equity ETF
Exchange:
CBOE
Establishment Date:
2025
Employees:
- -
Office Location:
3803 West Chester Pike,Suite 150,Newtown Square,Pennsylvania,United States
Zip Code:
19073
Fax:
216 245 3686
Introduction:
Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.